marcus evans north america conferences

7th Annual Pharma Resource Planning and Portfolio Management

Building Portfolio Value and Ensuring Higher Return of Investment by Utilizing Effective Resource Allocation Techniques

12-13 Mar 2014
Hyatt at the Bellevue - Philadelphia, PA, United States of America


Why You Should Attend

7th Annual Pharma Resource Planning and Portfolio Management

The 7th Annual Pharma Resource Planning and Portfolio Management Conference will take the delegation beyond the traditional approaches to program forecasting and budgetary allocations and put them in touch with cutting edge strategies and methodologies that will prepare them to achieve a comprehensive and balanced portfolio.

With growing competition, pharmaceutical and biotechnology companies are under increased pressure to deliver additional value for key stakeholders through their portfolios.  Companies with comprehensive portfolios offering more to physicians, patients, payers and pharmacists will have the competitive edge.  Achieving a balanced portfolio in terms of new product development, lifecycle management and business development and licensing is key to reducing risk and growing franchise sales.  With patent expiry of key blockbuster drugs, approaching lifecycle management is very popular but over reliance on this approach can damage long-term prospects.

Delegates get to experience a two day conference consisting of 16 highly interactive conference sessions, 10-15 minutes of Q&A time after each presentation and 4+ hours of networking with individuals involved in portfolio planning, resource management, project management, program management and other similar facets in the pharmaceutical portfolio planning industry.

 

Key Topics

  • Institute effective project prioritization protocols to optimize resource allocation across a given portfolio
  • Author protocols that ensure portfolio balance while diversifying risk and elevating ROI
  • Confront the effect of limited staffing on portfolio management to assess its impact on long term business development
  • Reduce portfolio spending during periods of financial uncertainty to maintain project development initiatives
  • Enhance the identification and management of known and emerging risks with a movement beyond traditional benchmarking of similar products
  • Previous Attendees Include

    AstraZeneca, Cantenion, Merck & Co., Johnson & Johnson Consumer, Genentech, Abbott Laboratories, Bristol-Myers Squibb, DuPuy Orthopaedics, Alnylam Pharmaceuticals


    Why Choose marcus evans?

    marcus evans specialises in the research and development of strategic events for senior business executives. From our international network of 63 offices, marcus evans produces over 1000 event days a year on strategic issues in corporate finance, telecommunications, technology, health, transportation, capital markets, human resources and business improvement.

    Above all, marcus evans provides clients with business information and knowledge which enables them to sustain a valuable competitive advantage and makes a positive contribution to their success.


    Event Sponsors
    Gold Sponsor
    Catenion
    Visit website >>
    Silver Sponsor
    Oracle
    Visit website >>
    Silver Sponsor
    Integrated Project Management
    Visit website >>
    Panel Partner
    Planisware
    Visit website >>
    Drinks Reception Sponsor
    Decision Lens Inc.
    Visit website >>
    Business Development Partner
    Thomson Reuters
    Visit website >>


    Event Partners

    • BioPortfolio

    • PharmaPhorum

    • Cutting

    • CanBiotech

    • PharmaVOICE

    • PharmaCast

    • BioSpace

    • Pharma


    Practical Insights From

    Ellen Donnelly, Ph.D
    Head of Portfolio, Strategy & Communications Neuroscience Research
    Pfizer, Inc.

    Joyce Pinkham
    Senior Director, Portfolio Management
    Cubist Pharmaceuticals, Inc.

    Rich Hall
    Director, Project and Portfolio Information Management
    GlaxoSmithKline

    Shama Kajiji, M.S., Ph.D., MBA
    Director, R&D Strategy and Portfolio Integration Project Management
    Janssen Pharmaceuticals, Inc.

    Simon Hornby
    Director, Clinical Capacity, Planning & Analytics
    MedImmune

    Cassia Cearley, Ph.D.
    Director, Corporate Portfolio Management
    Takeda Pharmaceuticals

    Eva M. Finney, Ph.D.
    Director, Global Project Management
    Merck & Co., Inc.

    Click Here For Full Agenda

    Voice of Our Customers
    • "Outstanding organization and excellent speakers set in a location conducive to first rate networking and quality learning." - Vitruvean
    • "I was exposed to some new concepts for portfolio/project/resource planning. Also got a very nice overview of what some big Pharmas (and other small pharmas or biotech companies through networking) are doing to be successful." - Bayer Corporation
    • "Absolutely wonderful event ! Keenly focused on strategies and issues directly influencing the industry; not just information but idea and solution generations." - Celgene Cellular Therapeutics
    Join the Discussion

    Follow on LinkedIn





    Event Contact

    For all enquiries regarding speaking, sponsoring and attending this conference contact:

    Michelle Thomas


    The NBC Tower
    455 N CityFront Plaza Drive
    Chicago, IL

    Telephone:
    312-894-6313
    Fax: 312 894 6304
    Email: MichelleT@marcusevansch.com